Hyperliquid 50x Whale Opens High-Leverage Short on BTC Again After 35 Days
According to a report by Jinse Finance, monitored by on-chain analyst Ember, Hyperliquid 50x whale @qwatio is once again opening high-leverage short positions on BTC. After a 35-day interval, this whale has once again opened a large leveraged contract position on Hyperliquid, using 2.683 million USDC as margin:
◉40x short on 888.8 BTC ($92.93 million), opening price $104,094, liquidation price $105,689.
◉10x short on 1 million LDO ($1.1 million), opening price $1.08, liquidation price $1.98.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
